← Back to catalogue
Disposable Blood Lines
EUDAMEDClass IIa (EU MDR)
Ref REFModel FB-AxxxVyy FB: Product Code A: Arterial Blood Pathway Code xxx: Specification code for arterial blood pathway, 001~006, 101~104 V: Venous Blood Pathway Code yy: Specification code for venous blood pathway, 01~05, 11~12
Identity
- Device Name
- Disposable Blood Lines EUDAMED
- Model / Reference
- FB-AxxxVyy FB: Product Code A: Arterial Blood Pathway Code xxx: Specification code for arterial blood pathway, 001~006, 101~104 V: Venous Blood Pathway Code yy: Specification code for venous blood pathway, 01~05, 11~12 EUDAMEDREF EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06941447200360 EUDAMED
- Basic UDI-DI
- 697426982FB01LM EUDAMED
- EMDN Code
- F020199 ARTERIOVENOUS DIALYSIS LINES FOR HAEMODIALYSIS - HAEMOFILTRATION -HAEMODIAFILTRATION - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Austria EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Disposable Blood Lines by Baihe Medical Technology (Wuhan) Co., Ltd. — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 697426982FB01LM | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Baihe Medical Technology (Wuhan) Co., Ltd.
- EUDAMED SRN
- CN-MF-000025832
- Authorised Representative
- Share info GmbH DE-AR-000005132
Sources (1)
- EUDAMED f020cd41-1473-4b65-8298-abb51ba8e873 61 fields · synced Jun 18, 2026